Roth Capital Decreases Earnings Estimates for Verona Pharma
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Stock analysts at Roth Capital lowered their Q2 2025 earnings estimates for Verona Pharma in a research report issued on Tuesday, April 29th. Roth Capital analyst B. Pachaiyappan now forecasts that the company will post earnings per share of ($0.16) for the quarter, down from their previous […]
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Stock analysts at Roth Capital lowered their Q2 2025 earnings estimates for Verona Pharma in a research report issued on Tuesday, April 29th. Roth Capital analyst B. Pachaiyappan now forecasts that the company will post earnings per share of ($0.16) for the quarter, down from their previous […]
